The iPS Cell Breakthroughs Reshaping Drug Discovery for Rare Disease
By modeling patients’ diseases in the laboratory and evaluating candidate drugs directly in human-derived cells, researchers like Okano Hideyuki of Keiō University are using iPS cells to open a new era in drug discovery. With Japan’s February 2026 announcement of a manufacturing system for an iPS cell-based therapy for spinal cord injury, the field is now entering a new phase of real-world implementation.
Black News 
By modeling patients’ diseases in the laboratory and evaluating candidate drugs directly in human-derived cells, researchers like Okano Hideyuki of Keiō University are using iPS cells to open a new era in drug discovery. With Japan’s February 2026 announcement of a manufacturing system for an iPS cell-based therapy for spinal cord injury, the field is now entering a new phase of real-world implementation.
